NeuroVasx is a medical device company engaged in the development and commercialization of technologies for the minimally-invasive treatment of hemorrhagic and ischemic strokes in the United States and internationally. The company offers cPAX, a polymer strand delivered through a micro catheter for the minimally-invasive treatment of hemorrhagic and ischemic strokes as well as for the embolization of cerebral and intracranial aneurysms, abnormal bulges, and sacs in the wall of an artery in the brain. Its products are used to treat acute stroke and other cerebrovascular disorders. NeuroVasx was founded in 1997 and is based in Maple Grove, Minnesota, United States.